Patent ID: 7208588
Filing Date: 2007-04-24
Classification: C07K,G01N

Abstract:
1. An isolated nucleic acid molecule having a nucleotide sequence selected from the group consisting of: a) the nucleotide sequence set forth in SEQ ID NO:1; b) a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NO:2; c) a nucleotide sequence having at least 90% sequence identity across the full length of the nucleotide sequence set forth in SEQ ID NO:1, wherein said nucleotide sequence having at least 90% sequence identity to the nucleotide sequence set forth in SEQ ID NO:1 encodes a polypeptide having d) a nucleotide sequence having at least 95% sequence identity across the full length of the nucleotide sequence set forth in SEQ ID NO:1, wherein said nucleotide sequence having at least 95% sequence identity to the nucleotide sequence set forth in SEQ ID NO:1 encodes a polypeptide having Bt Cry 1A toxin binding activity; e) the nucleotide sequence of the cDNA insert of the plasmid deposited with the ATCC as Patent Deposit No. PTA-4935; and f) a nucleotide sequence complementary across the full length of at least one nucleotide sequence set forth in a), b), c), d), or e).